Scientists start work on steps needed for potential rapid development of a modified vaccine, AstraZeneca says

The UK medicines regulator is in discussions with coronavirus vaccine manufacturers about “potential modifications” that may be needed to ensure their jabs protect against new variants of the virus.

The Medicines and Healthcare products Regulatory Agency (MHRA) said there was no evidence that vaccines failed to work against the new variants that emerged in recent months, but said it had made the issue a priority.

Continue reading…

You May Also Like

France: teen shot by police given private funeral as crisis grips government

President Macron cancels visit to Germany amid France’s worst violence for 18…

Annie Ernaux wins the 2022 Nobel prize in literature

The French author of mostly autobiographical work takes the prestigious books prize…